Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 529 of 6351
-
New heart artery treatment could save millions: hybrid strategy tested against standard stenting
Disease control Not yet recruitingThe number of deaths from heart disease is rising globally, particularly in developing countries. This condition involves the narrowing of arteries that supply blood to the heart. The most critical narrowing occurs in the left main coronary artery (LMCA), which supplies blood to …
Sponsor: Hospital Sultanah Bahiyah • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New spray chemotherapy trial targets Hard-to-Treat ovarian cancer
Disease control Not yet recruitingThe purpose of this study is to evaluate the tolerance, safety, efficacy, and pharmacokinetics of pressurized intraperitoneal aerosol chemotherapy (PIPAC) with paclitaxel in patients with platinum-resistant recurrent ovarian cancer and peritoneal carcinomatosis.
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Immunotherapy plus chemo shows promise in rectal cancer trial
Disease control Not yet recruitingThis study is a single-center, prospective, randomized, double-arm, Phase II clinical trial designed to evaluate the efficacy of radiotherapy combined with CAPOX, and Iparomlimab and Tuvonralimab (QL1706) as neoadjuvant therapy for locally advanced rectal cancer. Additionally, th…
Phase 2 • Sponsor: Zhongnan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
AI doctor in the ICU: can ChatGPT-5 save lives?
Knowledge-focused Not yet recruitingThis is a prospective, unmasked, randomized, multicenter clinical trial evaluating the impact of point-of-care large language model (LLM)-based decision support on diagnostic accuracy and clinical outcomes in adult medical intensive care unit (MICU) patients. Consecutive adult I…
Phase 1/2 • Sponsor: MetroWest Artificial Intelligence Research Workgroup • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New hope for hard-to-treat lymphoma: three-drug combo enters early trials
Disease control Not yet recruitingThis trial is a proof-of-concept, pilot study, phase I/II clinical trial aimed at generating preliminary data on the combination of golcadomide, poseltinib, and rituximab.
Phase 1/2 • Sponsor: Seoul National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Could a simple pill before surgery beat back head and neck cancer?
Disease control Not yet recruitinghead and neck squamous cell carcinoma (HNSCC) is a type of cancer that affects areas such as the mouth, throat, and voice box. Despite medical progress, little has changed in the care for patients with HPV-negative cancer. The standard care involves surgery followed by radiation …
Phase 2 • Sponsor: Sir Mortimer B. Davis - Jewish General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Drug duo aims to turn inoperable lung cancer into surgical candidates
Disease control Recruiting nowThis study is a prospective, single-arm, exploratory clinical research aimed at evaluating the efficacy and safety of lucetamab in combination with leucovorin in the conversion therapy of locally advanced potentially resectable EGFR mutation-positive non-small cell lung cancer, p…
Phase 2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New cocktail of drugs shows promise for tough bile duct cancer
Disease control Not yet recruitingEvaluation of Efficacy and Safety of Sintilimab Plus Bevacizumab and AG Regimen as First-Line Therapy in Patients with Surgically Ineligible Locally Advanced or Metastatic Cholangiocarcinoma Objectives: Primary Objective: To assess the objective response rate (ORR) as per RECI…
Phase 2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New scanner could slash repeat breast surgeries
Diagnosis Not yet recruitingAccurate intraoperative margin assessment in breast cancer surgery remains challenging. Current reliance on frozen section pathology is limited by prolonged processing time, sampling constraints, and resource intensity, contributing to variable outcomes. The EndoSCell Scanner is…
Sponsor: West China Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Engineered immune cells take on stomach cancer in new trial
Disease control Not yet recruitingThis is a single-arm, open-label clinical study evaluating the safety and preliminary efficacy of a novel hypoxia-inducible, bispecific CD73/AXL-targeting CAR-T cell product, XW-LTH-03, in patients with stage IV gastric cancer (GC). The primary objective is to assess the safety a…
Phase 1/2 • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental vaccine aims to boost immune attack on glioblastoma
Disease control Not yet recruitingGlioblastomas (GBM) are the most frequent brain tumors and one of the most lethal adult cancers despite maximal multimodal therapy. Despite maximal safe resection followed by radiotherapy and temozolomide (TMZ) ± tumor-treating fields, median overall survival for newly diagnosed …
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New CAR-T therapy targets tough blood cancers in early trial
Disease control Recruiting nowThis is a prospective, single-arm, multi-center, randomized controlled clinical study designed to evaluate the safety and efficacy of BAFFR CAR-T therapy for relapsed/refractory B-cell malignancies. A total of 30 subjects are planned to be enrolled.
Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New suicide prevention program aims to save Women's lives in tajikistan
Prevention By invitation onlyThe study takes place in Tajikistan, a postwar country in Central Asia, where Dr. Weine, Dr. Pirova, Dr. Bahromov, and other collaborators successfully implemented a D43 research capacity building project and an R21 and R01 on stepped care for women's mental health in primary car…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
New immunotherapy combo shows promise for stubborn lymphoma
Disease control OngoingIn patients with relapsed or refractory diffuse DLBCL who have not achieved complete remission in the mid-term, the treatment with Glofit+GemOx regimen is used.
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Liver cancer screening trial aims to cut deaths in cirrhosis patients
Prevention Recruiting nowThis study aims to investigate whether repeated 6-monthly screening for hepatocellular carcinoma (HCC) - called "HCC surveillance" - offered to selected patients with chronic liver disease can reduce HCC-related mortality by facilitating earlier detection of HCC. The screening pr…
Sponsor: University of Aarhus • Aim: Prevention
Last updated Jun 27, 2026 11:01 UTC
-
New hope for aggressive lymphoma: precision therapy trial launches
Disease control Recruiting nowTo evaluate the efficacy and safety of Genetic subtype-matched targeted therapy in the treatment of treatment-naive diffuse large B-cell lymphoma with TP53 mutation.
Phase 2 • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could vitamin d predict cervical cancer treatment success?
Knowledge-focused Recruiting nowBackground. Definitive chemoradiotherapy represents the standard therapeutic approach for the management of locally advanced cervical cancer. Vitamin D plays an important role in the regulation of cellular growth and differentiation, immune system function, and the modulation of …
Sponsor: University of Kragujevac • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
Could a common asthma drug shorten bronchiolitis hospital stays?
Disease control Recruiting nowThis study aims to evaluate the role of Montelukast in management of acute Bronchiolitis in indoor patient and how this drug shortens the duration of admission and improves symptoms
Phase 2 • Sponsor: Pakistan Institute of Medical Sciences • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Could simple exercises rebuild strength after chemotherapy nerve damage?
Symptom relief CompletedForty-eight participants between the age of 35 to 55years patient treated with Taxane chemotherapy, will be randomly divided into two equal groups, each comprising 24 patients. * Group (A): Consists of twenty- four patients have chemo therapy Induced peripheral Neuropathy and wi…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Aug 21, 2026 00:00 UTC
-
Could a staged fistula treatment be safely skipped?
Disease control Recruiting nowCryptoglandular anal fistulas can cause pain, discharge, recurrent infection, and a prolonged treatment course. In current practice, patients with a single-tract mid-high or high cryptoglandular anal fistula often first undergo placement of a loose seton before definitive sphinct…
Sponsor: Proctos Kliniek • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC